People

A Selection of Speakers and Mentors in Our Network

Evan

Software Engineer at OpenAI

Evan is a technical software engineer at OpenAI, focused on artificial general intelligence. He previously held software engineering roles at Meta and led his own venture-backed startup. He studied Computer Science and Entrepreneurship at Johns Hopkins University.

Artificial Intelligence / Software Engineering

Jasmine

Technical Program Manager at Microsoft

Jasmine is a Technical Program Manager at Microsoft, where she works on AI-powered products in the Xbox gaming division. She earned her degree in Electrical Engineering and Computer Science + Business through UC Berkeley’s prestigious M.E.T. program.

Technology / Gaming / Program Management / Artificial Intelligence

Phil

J.D. Harvard Law School, Legal Tech Founder/CEO

Phillip is a JD graduate from Harvard Law School with experience across legal tech, private equity, and BigLaw. He previously worked at Deloitte Consulting and holds a degree in International Politics from Brown University.

Law / Legal Technology

Lani

Investment Banker at Morgan Stanley

Lani is a Technology Investment Banking Analyst at Morgan Stanley, where he works in the Global Technology Group advising growth-stage companies. He earned his degree in History and Economics from Columbia University.

Finance – Investment Banking

Azizamosi

Product Marketing Manager at Google

Azizamosi is a Product Marketing Manager at Google Cloud, where she focuses on AI-driven products. She studied at Cornell University, where she concentrated in global communications and digital strategy.

Marketing / Cloud & AI

Johnny

M.D. Candidate at Stanford Medicine

Johnny is an MD candidate at Stanford University School of Medicine and a Knight-Hennessy Scholar. He graduated cum laude from Harvard University with a degree in Chemistry and a minor in Psychology, and previously worked as an Associate Consultant at Bain & Company. His background includes research at the University of Chicago focused on health equity and representation in clinical trials.